Exercise and Blood Glucose Levels in Patients with Type I Diabetes - a Pilot Study

Medizinische Universität Graz/Endokrinologie und Stoffwechsel0 个研究点开始时间: 2014年1月8日最近更新: 2014年2月3日

适应症

试验速览

暂无简介。

•Subjects must give their signed and dated informed consent before any trial-related activities. Trial-related activities are any procedure that would not have been performed during normal management of the subject
•Male subjects with type 1 diabetes with duration =12 month
•Age = 18 to = 35 years, both inclusive
•HbA1c = 64 mmol/mol
•Fasting C-peptide negative (= 0.3 nmol/l)
•Treatment with intensified insulin therapy or insulin pump therapy
•No diabetic long term complications
•No other physical and/or mental disease
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 7
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Previous participation (randomisation) in this trial
•History of any illness or disease that, in the opinion of the Investigator might confound the results of the trial
•Use of drugs, which may interfere with the interpretation of trial results or are known to cause clinically relevant interference with insulin action, glucose utilisation, or recovery from hypoglycemia
•Current addiction to alcohol or substances of abuse as determined by the investigator
•Known or suspected allergy to trial products or related products
•Any condition that the investigator feels would interfere with the trial participation or evaluation of data
•Testing day inclusion criteria:
•48h before testing no hypoglycemia
•24h before testing no alcohol

发起方

Medizinische Universität Graz/Endokrinologie und Stoffwechsel